相关实验视频
Updated: Jul 28, 2025

08:35
Demonstration of the Rat Ischemic Skin Wound Model
Published on: April 1, 2015
21.4K
通过通过NF-κB信号通路诱导TIMP-1表达,RIG-I有助于角质细胞的增殖和伤口修复
Huiyuan Zhu1, Qianyu Li1, Qiongyi Huang1
1Department of Pathology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Journal of cellular physiology
|June 3, 2023
概括
网红酸诱导基因I (RIG-I) 通过促进TIMP-1驱动状细胞的增殖和伤口修复. 缺少RIG-I会恶化皮肤损伤,突出其治疗潜力,治疗糖尿病足等慢性伤口.
科学领域:
- 皮肤病学和伤口愈合研究.
- 细胞增殖的分子机制.
- 免疫学和炎症途径.
背景情况:
- 皮质角质细胞的增殖对于伤口修复至关重要.
- 慢性伤口,如糖尿病足,表现出重新上皮质化受损.
- 异常的细胞信号导致伤口愈合延迟.
研究的目的:
- 调查视网膜酸诱导基因I (RIG-I) 在角质细胞增殖和TIMP-1表达中的作用.
- 阐明RIG-I影响伤口修复的机制.
- 评估RIG-I作为慢性伤口的潜在治疗点.
主要方法:
- 在皮肤损伤和糖尿病小鼠模型中RIG-I表达的分析.
- 在体内和体外研究RIG-I对角质细胞增殖和伤口愈合的影响.
- 使用NF-κB信号通路分析和重组TIMP-1治疗.
主要成果:
- 在皮肤损伤的角质细胞中,RIG-I过度表达,但在糖尿病足部伤口中表达不足.
- 缺乏RIG-I的小鼠表现出皮肤损伤表型的恶化.
- RIG-I通过诱导TIMP-1通过NF-κB信号传递来促进角质细胞的增殖和伤口修复.
- 重组TIMP-1加速了细胞增殖,促进了伤口愈合.
结论:
- RIG-I是表皮角质细胞增殖和伤口修复的关键调解者.
- RIG-I对TIMP-1的诱导是治愈的关键机制.
- RIG-I可以作为皮肤损伤严重程度的生物标志物,以及糖尿病足的治疗.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

